PATENT CLAIM ANALYSIS

Application Number: 16181628
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "001650"]

Abstract:
Among the various aspects of the present disclosure is the provision of compositions and methods for imaging and treating subjects with amyloidosis or multiple myeloma with or without amyloidosis.

Claim (Index 2):
The imaging agent of  claim 1 , wherein the high affinity corresponds to a Kd value less than about 600 pmol or the heterocyclic molecule has a Kd of at most about 600 pmol.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.30435
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13314160', '15026545', '12811049', '15552614', '15258883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7066879017366503
- 35 USC 102 Novelty (BERT): 0.5105883959865745
- Combined Prediction Score: 0.6870779511616427
- Mean Citation Score: 167.89954399999996
- Max Citation Score: 173.50372
- Similarity Product: 91.38447481545924

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test